BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $538,000 | +33.2% | 417,433 | +8.6% | 0.01% | +55.6% |
| Q3 2019 | $404,000 | -81.5% | 384,427 | -70.1% | 0.01% | -83.6% |
| Q2 2019 | $2,184,000 | -53.0% | 1,284,955 | -6.9% | 0.06% | -58.6% |
| Q1 2019 | $4,649,000 | +54.0% | 1,379,629 | +33.5% | 0.13% | +8.1% |
| Q4 2018 | $3,018,000 | -17.0% | 1,033,491 | +75.1% | 0.12% | +11.8% |
| Q3 2018 | $3,636,000 | +73.6% | 590,214 | +108.0% | 0.11% | +42.9% |
| Q2 2018 | $2,094,000 | – | 283,772 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |